BRIEF published on 12/09/2024 at 09:00, 1 year 9 months ago CEO Andreas Wegerich Initiates Partial Management Buy-Out at Nakiki SE Investment Strategy NAKIKI SE Corporate Growth Andreas Wegerich Management Buy-Out
PRESS RELEASE published on 12/09/2024 at 08:55, 1 year 9 months ago Partial Management Buy-Out by CEO Andreas Wegerich CEO Andreas Wegerich of Nakiki SE plans a partial management buy-out, acquiring up to 29% of company shares for long-term growth and strategic development Strategic Growth NAKIKI SE Company Shares Andreas Wegerich Management Buy-Out
BRIEF published on 10/10/2024 at 09:26, 1 year 11 months ago Nakiki SE Signs Letter of Intent for Lawsuit Worth Up to One Million Euros Lawsuit Letter Of Intent Financial Strategy NAKIKI SE Inheritance Determination
PRESS RELEASE published on 10/10/2024 at 09:21, 1 year 11 months ago EQS-Adhoc: Nakiki SE: Letter of Intent for New Lawsuit up to One Million Euros Nakiki SE signs Letter of Intent for financing an inheritance determination lawsuit up to 1 million euros, entitled to 33% share of litigation success Financing Lawsuit Letter Of Intent NAKIKI SE Litigation Success
BRIEF published on 10/08/2024 at 13:35, 1 year 11 months ago Nakiki SE Signs Letter of Intent for Lawsuit Financing NAKIKI SE Hamburg Lawsuit Financing Construction Defects Litigation Success
PRESS RELEASE published on 10/08/2024 at 13:30, 1 year 11 months ago EQS-Adhoc: Nakiki SE: Letter of Intent for New Lawsuits (up to EUR 2.4 Million) Nakiki SE signs Letter of Intent for lawsuits financing up to EUR 2.4 million due to construction defects. Entitled to 33% of litigation success Letter Of Intent NAKIKI SE Construction Defects Litigation Success Lawsuits Financing
BRIEF published on 09/21/2024 at 09:53, 2 years ago Nakiki SE: Mask Lawsuits Will Not Be Financed NAKIKI SE COVID Masks Litigation Funding Legal Matter Supply Contracts
PRESS RELEASE published on 09/21/2024 at 09:48, 2 years ago EQS-Adhoc: Nakiki SE: Mask lawsuits will not be financed Nakiki SE will not finance 'mask lawsuits' against the government for COVID mask supply contracts after careful evaluation, but remains open to financing such claims NAKIKI SE COVID Masks Litigation Funding Mask Lawsuits Legal Evaluation
BRIEF published on 08/27/2024 at 09:02, 2 years ago Nakiki SE Investigates First Capital Market Claim Worth EUR 400,000 Growth Strategy NAKIKI SE Litigation Financing Securities Law Capital Market Claim
PRESS RELEASE published on 08/27/2024 at 08:57, 2 years ago Nakiki SE: Examination of first capital market claim Nakiki SE explores capital market claim for potential litigation financing, expanding into new business area. With legal experts, aims to maximize plaintiffs' success Investors NAKIKI SE Litigation Financing Legal Protection Capital Market Claim
Published on 09/21/2026 at 15:45, 4 hours 16 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 5 hours 41 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 5 hours 56 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 6 hours 1 minute ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 6 hours 16 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 18:00, 2 hours 1 minute ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 2 hours 16 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 2 hours 16 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 3 hours 1 minute ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 1 hour 42 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 hour 59 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 2 hours 15 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 07:00, 13 hours 1 minute ago Peugeot Invest takes a stake in Mérieux NutriSciences
